Onconetix 

0
55
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2024
Q1 2026
Q2 2026
Next
-33,282.4
-22,521.26
-11,760.13
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,984.92%Profit Margin
Unprofitable
2021
2022
2023
2024
2025
701,445.63Revenue
-13.92MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow J4T.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Show more...
CEO
David Allan White
Employees
2
Country
United States
ISIN
US68237Q4010
WKN
000A42ANX

Listings

0 Comments

Share your thoughts

FAQ

What is Onconetix stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Onconetix stocks are traded under the ticker J4T.STU.
When is the next Onconetix earnings date?
Onconetix is going to release the next earnings report on November 12, 2026.
What is Onconetix revenue for the last year?
Onconetix revenue for the last year amounts to 701,445.63 EUR.
What is Onconetix net income for the last year?
J4T.STU net income for the last year is -13.92M EUR.
How many employees does Onconetix have?
As of September 04, 2026, the company has 2 employees.
In which sector is Onconetix located?
Onconetix operates in the Health & Wellness sector.
When did Onconetix complete a stock split?
The last stock split for Onconetix was on May 21, 2026 with a ratio of 1:10.
Where is Onconetix headquartered?
Onconetix is headquartered in CINCINNATI, United States.